Additional Features in the Treatment of Patients with Chronic Heart Failure. From EMPA-REG OUTCOME Study to EMPEROR-REDUCED Study. Resolution of the On-line Scientific Meeting of Moscow Experts
The results of the international multicenter study EMPEROR-REDUCED were reviewed the on-line scientific meeting of Moscow experts on October 30, 2020. Some proposals and recommendations for further study of the cardiovascular and renal effects of empagliflozin and its use in clinical practice in pat...
| Main Authors: | , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Столичная издательская компания
2021-03-01
|
| Series: | Рациональная фармакотерапия в кардиологии |
| Subjects: | |
| Online Access: | https://www.rpcardio.online/jour/article/view/2402 |
| _version_ | 1797232095721947136 |
|---|---|
| author | A. Yu. Lebedeva O. M. Koteshkova O. N. Dzhioeva S. R. Gilyarevsky T. M. Uskach M. S. Novikova Ya. A. Orlova V. Yu. Kalashnikov D. V. Privalov N. A. Ananicheva M. Yu. Gilyarov A. D. Erlikh |
| author_facet | A. Yu. Lebedeva O. M. Koteshkova O. N. Dzhioeva S. R. Gilyarevsky T. M. Uskach M. S. Novikova Ya. A. Orlova V. Yu. Kalashnikov D. V. Privalov N. A. Ananicheva M. Yu. Gilyarov A. D. Erlikh |
| author_sort | A. Yu. Lebedeva |
| collection | DOAJ |
| description | The results of the international multicenter study EMPEROR-REDUCED were reviewed the on-line scientific meeting of Moscow experts on October 30, 2020. Some proposals and recommendations for further study of the cardiovascular and renal effects of empagliflozin and its use in clinical practice in patients with chronic heart failure with reduced ejection fraction were accepted. |
| first_indexed | 2024-03-08T14:01:10Z |
| format | Article |
| id | doaj.art-8642d167fac5420cbea6c65fee3a0b3e |
| institution | Directory Open Access Journal |
| issn | 1819-6446 2225-3653 |
| language | English |
| last_indexed | 2024-04-24T15:54:50Z |
| publishDate | 2021-03-01 |
| publisher | Столичная издательская компания |
| record_format | Article |
| series | Рациональная фармакотерапия в кардиологии |
| spelling | doaj.art-8642d167fac5420cbea6c65fee3a0b3e2024-04-01T07:43:40ZengСтоличная издательская компанияРациональная фармакотерапия в кардиологии1819-64462225-36532021-03-0117116516810.20996/1819-6446-2021-01-031854Additional Features in the Treatment of Patients with Chronic Heart Failure. From EMPA-REG OUTCOME Study to EMPEROR-REDUCED Study. Resolution of the On-line Scientific Meeting of Moscow ExpertsA. Yu. LebedevaO. M. KoteshkovaO. N. DzhioevaS. R. GilyarevskyT. M. UskachM. S. NovikovaYa. A. OrlovaV. Yu. KalashnikovD. V. PrivalovN. A. AnanichevaM. Yu. GilyarovA. D. ErlikhThe results of the international multicenter study EMPEROR-REDUCED were reviewed the on-line scientific meeting of Moscow experts on October 30, 2020. Some proposals and recommendations for further study of the cardiovascular and renal effects of empagliflozin and its use in clinical practice in patients with chronic heart failure with reduced ejection fraction were accepted.https://www.rpcardio.online/jour/article/view/2402empagliflozinchronic heart failurecardiovascular mortalitychronic kidney diseaseemperor-reduced study |
| spellingShingle | A. Yu. Lebedeva O. M. Koteshkova O. N. Dzhioeva S. R. Gilyarevsky T. M. Uskach M. S. Novikova Ya. A. Orlova V. Yu. Kalashnikov D. V. Privalov N. A. Ananicheva M. Yu. Gilyarov A. D. Erlikh Additional Features in the Treatment of Patients with Chronic Heart Failure. From EMPA-REG OUTCOME Study to EMPEROR-REDUCED Study. Resolution of the On-line Scientific Meeting of Moscow Experts Рациональная фармакотерапия в кардиологии empagliflozin chronic heart failure cardiovascular mortality chronic kidney disease emperor-reduced study |
| title | Additional Features in the Treatment of Patients with Chronic Heart Failure. From EMPA-REG OUTCOME Study to EMPEROR-REDUCED Study. Resolution of the On-line Scientific Meeting of Moscow Experts |
| title_full | Additional Features in the Treatment of Patients with Chronic Heart Failure. From EMPA-REG OUTCOME Study to EMPEROR-REDUCED Study. Resolution of the On-line Scientific Meeting of Moscow Experts |
| title_fullStr | Additional Features in the Treatment of Patients with Chronic Heart Failure. From EMPA-REG OUTCOME Study to EMPEROR-REDUCED Study. Resolution of the On-line Scientific Meeting of Moscow Experts |
| title_full_unstemmed | Additional Features in the Treatment of Patients with Chronic Heart Failure. From EMPA-REG OUTCOME Study to EMPEROR-REDUCED Study. Resolution of the On-line Scientific Meeting of Moscow Experts |
| title_short | Additional Features in the Treatment of Patients with Chronic Heart Failure. From EMPA-REG OUTCOME Study to EMPEROR-REDUCED Study. Resolution of the On-line Scientific Meeting of Moscow Experts |
| title_sort | additional features in the treatment of patients with chronic heart failure from empa reg outcome study to emperor reduced study resolution of the on line scientific meeting of moscow experts |
| topic | empagliflozin chronic heart failure cardiovascular mortality chronic kidney disease emperor-reduced study |
| url | https://www.rpcardio.online/jour/article/view/2402 |
| work_keys_str_mv | AT ayulebedeva additionalfeaturesinthetreatmentofpatientswithchronicheartfailurefromemparegoutcomestudytoemperorreducedstudyresolutionoftheonlinescientificmeetingofmoscowexperts AT omkoteshkova additionalfeaturesinthetreatmentofpatientswithchronicheartfailurefromemparegoutcomestudytoemperorreducedstudyresolutionoftheonlinescientificmeetingofmoscowexperts AT ondzhioeva additionalfeaturesinthetreatmentofpatientswithchronicheartfailurefromemparegoutcomestudytoemperorreducedstudyresolutionoftheonlinescientificmeetingofmoscowexperts AT srgilyarevsky additionalfeaturesinthetreatmentofpatientswithchronicheartfailurefromemparegoutcomestudytoemperorreducedstudyresolutionoftheonlinescientificmeetingofmoscowexperts AT tmuskach additionalfeaturesinthetreatmentofpatientswithchronicheartfailurefromemparegoutcomestudytoemperorreducedstudyresolutionoftheonlinescientificmeetingofmoscowexperts AT msnovikova additionalfeaturesinthetreatmentofpatientswithchronicheartfailurefromemparegoutcomestudytoemperorreducedstudyresolutionoftheonlinescientificmeetingofmoscowexperts AT yaaorlova additionalfeaturesinthetreatmentofpatientswithchronicheartfailurefromemparegoutcomestudytoemperorreducedstudyresolutionoftheonlinescientificmeetingofmoscowexperts AT vyukalashnikov additionalfeaturesinthetreatmentofpatientswithchronicheartfailurefromemparegoutcomestudytoemperorreducedstudyresolutionoftheonlinescientificmeetingofmoscowexperts AT dvprivalov additionalfeaturesinthetreatmentofpatientswithchronicheartfailurefromemparegoutcomestudytoemperorreducedstudyresolutionoftheonlinescientificmeetingofmoscowexperts AT naananicheva additionalfeaturesinthetreatmentofpatientswithchronicheartfailurefromemparegoutcomestudytoemperorreducedstudyresolutionoftheonlinescientificmeetingofmoscowexperts AT myugilyarov additionalfeaturesinthetreatmentofpatientswithchronicheartfailurefromemparegoutcomestudytoemperorreducedstudyresolutionoftheonlinescientificmeetingofmoscowexperts AT aderlikh additionalfeaturesinthetreatmentofpatientswithchronicheartfailurefromemparegoutcomestudytoemperorreducedstudyresolutionoftheonlinescientificmeetingofmoscowexperts |